Ultragenyx Community Update October 2024
The Phase 3 Efficacy and Safety Study of GTX-102 (ASO) in Pediatrics, sponsored by Ultragenyx, is now listed on ClinicalTrials.gov. Interested in learning more? Watch the Ultragenyx Community Webinar
The Phase 3 Efficacy and Safety Study of GTX-102 (ASO) in Pediatrics, sponsored by Ultragenyx, is now listed on ClinicalTrials.gov. Interested in learning more? Watch the Ultragenyx Community Webinar
Find information on Angelman syndrome, research, clinical trials, resources, and ways to get involved.